The coronavirus-mandated shelter-in-place orders of 2020 have boosted the. This reality also could impact stock performance. Zoom Stock Ran Too Far, Too Fast in 2020. That said, even with positive results in a relatively small sample size, there is no guarantee that Pfizer’s vaccine will be approved or will work on a wide-scale. Conversely, work-from-home stocks like Peloton could suffer as more people may opt to exercise in a gym, rather than inside their home. Zoom said it expects adjusted profit of 78 cents at the midpoint of its. Here are some other sectors to watch for:Įssentially, any business that could thrive when in-person activity increases is a potential winner in this scenario. For the current quarter ending in January, Zoom forecast revenue of 808.5 million vs. Other stocks outside the healthcare sector could benefit with the approval of a potential vaccine. Tuesday that it plans to raise 1.5 billion in new capital from the sale of about 4.2 million new shares of its. While a 20% stock price drop is relatively small against the backdrop of year-to-date performance, it could be a sign of further downward pressure on Zoom’s share price if the vaccine receives regulatory and marketing approval. Stock Advisor returns as of November 20, 2020.
If more people return to in-person work or if social distancing rules are eased, or both, fewer people could use Zoom. A potential vaccine, if effective and if widely distributed, implies that Zoom’s growth and user base could slow.
0 kommentar(er)
